Domainex is committed to the support of exciting and cutting edge translational research. From its foundations out of The Institute of Cancer Research (ICR), Birkbeck College and UCL, to its on-going work with St George’s University, The University of Manchester and ICR; Domainex has exemplified how academic-private sector drug discovery collaborations can succeed and be beneficial to all parties.
Domainex has therefore launched its Discovery STAR award, to support the early stages of drug discovery for a chosen number of applicants to the scheme. At Domainex’s discretion, selected applicants will then be provided with drug discovery advice and/or virtual hit screening free of charge in order to prepare applicants for funding applications to schemes such as the Wellcome Trust SDDI, Technology Strategy Board, Biomedical Catalyst Fund or MRC DPFS .
Domainex will operate this scheme once a year. The next round deadline is shown below. If you have questions, please contact
Joanne McCudden at firstname.lastname@example.org.
In order to apply, please provide us with the following details:
No compound purchase from 3rd parties is included and the cost of these must be found by the award recipient.
No cash alternatives to the award available.